Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway
Liver fibrosis is an important stage in the progression of liver injury into cirrhosis or even liver cancer. Hepatic stellate cells (HSCs) are induced by transforming growth factor-β1 (TGF-β1) to produce α-smooth muscle actin (α-SMA) and collagens in liver fibrosis. Butaselen (BS), which was previou...
Main Authors: | Wenxuan Jiao, Man Bai, Hanwei Yin, Jiayi Liu, Jing Sun, Xiaoxia Su, Huihui Zeng, Jinhua Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.690170/full |
Similar Items
-
Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis
by: Giulia Chiabotto, et al.
Published: (2020-12-01) -
Interaction of recombinant form of NADPH-dependent thioredoxin reductase from rice with thioredoxin from two plant and bacterial sources
by: Hadiyeh Eslam Panah, et al.
Published: (2014-08-01) -
Fluorogenic probes for thioredoxin reductase activity
by: Tendai J. Mafireyi, et al.
Published: (2021-01-01) -
Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
by: Vanessa Pires, et al.
Published: (2022-06-01) -
The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-10-01)